LEUCADIA THERAPEUTICS INC.
Leucadia Therapeutics Inc is a California-based company working on neurological disorders, using Machine Learning, clinical imaging, and behavioral testing. LMT is part of the company&s;s approach to addressing the underlying cause of Alzheimer&s;s disease. It may allow them to predict who will get the disease and when years before cognitive impairment begins. Leucadia&s;s Deep Learning algorithm uses CT scans, LMT, and other measures. Clinical trials with Leucadia&s;s interventional device Arethusta®, a prophylactic device that restores the clearance of toxins that may seed Alzheimer&s;s disease pathology, are slated to begin in 2022.
Country/Area ：United States
Company Email ：info@leucadiatx.com
Industry ：Business ServicesBusiness Services GeneralBig Data
Company address ：6761 Brockton Av Suite 100 Riverside Riverside Ca92506 Us
Company website ：*****
Established ：2015
Company Revenue ：$1,541,000
Number of employees ：<25
SIC Code ：87873
NAICS Code ：54541
Company News
Prominent Neurosurgeon Joins Leucadia Therapeutics as Company&s;s Founding Global Chief Medical Officer
Aug 22, 2022
Javed Siddiqi, who created neuroscience programs in multiple hospitals, brings skull base expertise as company readies preclinical studies to assess Arethusta® effectiveness SAN DIEGO, Aug. 22, 2022 /PRNewswire/ -- Leucadia Therapeutics, a company working to cure Alzheimer&s;s disease, has...
Aug 22, 2022
Former Global Fund Manager Joins Leucadia Therapeutics as Company&s;s First CFOAug 15, 2022
Edward Shadek, Jr., former deputy chief of Investments at Putnam, brings wealth of financial acumen as company prepares for clinical trials SAN DIEGO, Aug. 15, 2022 /PRNewswire/ -- Leucadia Therapeutics, a company working to cure Alzheimer&s;s disease with a medical device implanted by...
Aug 15, 2022Alzheimer&s;s Disease Researchers Release Free Memory Tracking AppJul 9, 2021
SAN DIEGO, July 9, 2021 /PRNewswire/ -- Today, Leucadia Therapeutics Inc, a California HealthTech Company, is launching 8 Apps that help exercise memory and cognition, including a personalized memory tracker called ProCogny (procogny.com). ProCogny allows users to play memory-intensive...
Jul 9, 2021Web Summary
Q1: What is the company name and its address?
A1: The company name is Leucadia Therapeutics Inc., but unfortunately, the provided content does not explicitly mention its physical address.
Q2: What is the main product or treatment being developed by Leucadia Therapeutics?
A2: According to the text, Leucadia Therapeutics is working on a first-in-class outpatient treatment called Arethusta, which aims to reverse mild cognitive impairment associated with Alzheimer's disease and eventually prevent and cure Alzheimer's itself.
Q3: What is Project Cribrose, and how does it relate to Leucadia Therapeutics?
A3: Project Cribrose is a collaboration between Leucadia Therapeutics and neurosurgeons at Arrowhead Regional Medical Center in Colton, California. It involves a 2,000-person clinical study to assess the risk of Alzheimer's disease using a proprietary diagnostic tool that includes a 20-second CT scan and cognitive tests.
Q4: What is the industry or field that Leucadia Therapeutics operates in?
A4: Based on the provided content, it appears that Leucadia Therapeutics operates in the pharmaceutical and biotechnology industries, specifically in the area of Alzheimer's disease treatment.
Q5: How can individuals participate in Project Cribrose and assess their risk of developing Alzheimer's disease?
A5: According to the text, individuals can enroll in the 2,000-person clinical study by visiting the Leucadia Therapeutics website or contacting the company directly. Participants will undergo a series of tests, including a 20-second CT scan and cognitive tests.
Q6: What is the contact information for Leucadia Therapeutics?
A6: Unfortunately, the provided content does not explicitly mention the phone number or email address for Leucadia Therapeutics. However, the company's website provides a contact form and other ways to get in touch with them.
Q7: What is the status of Leucadia Therapeutics' web site, and what information can be found on it?
A7: The text states that Leucadia Therapeutics' web site is provided as a service only and may not always contain the most current information. However, updates will be made frequently. The site includes sections for news, science, about us, contact, and legal notices.
Q8: What is the company's stance on data protection and privacy?
A8: According to the Privacy Policy section of the website, Leucadia Therapeutics is committed to protecting user information and has implemented measures to ensure its security. However, users are advised to review any information with their individual physician or medical practitioner for specific medical advice.
A1: The company name is Leucadia Therapeutics Inc., but unfortunately, the provided content does not explicitly mention its physical address.
Q2: What is the main product or treatment being developed by Leucadia Therapeutics?
A2: According to the text, Leucadia Therapeutics is working on a first-in-class outpatient treatment called Arethusta, which aims to reverse mild cognitive impairment associated with Alzheimer's disease and eventually prevent and cure Alzheimer's itself.
Q3: What is Project Cribrose, and how does it relate to Leucadia Therapeutics?
A3: Project Cribrose is a collaboration between Leucadia Therapeutics and neurosurgeons at Arrowhead Regional Medical Center in Colton, California. It involves a 2,000-person clinical study to assess the risk of Alzheimer's disease using a proprietary diagnostic tool that includes a 20-second CT scan and cognitive tests.
Q4: What is the industry or field that Leucadia Therapeutics operates in?
A4: Based on the provided content, it appears that Leucadia Therapeutics operates in the pharmaceutical and biotechnology industries, specifically in the area of Alzheimer's disease treatment.
Q5: How can individuals participate in Project Cribrose and assess their risk of developing Alzheimer's disease?
A5: According to the text, individuals can enroll in the 2,000-person clinical study by visiting the Leucadia Therapeutics website or contacting the company directly. Participants will undergo a series of tests, including a 20-second CT scan and cognitive tests.
Q6: What is the contact information for Leucadia Therapeutics?
A6: Unfortunately, the provided content does not explicitly mention the phone number or email address for Leucadia Therapeutics. However, the company's website provides a contact form and other ways to get in touch with them.
Q7: What is the status of Leucadia Therapeutics' web site, and what information can be found on it?
A7: The text states that Leucadia Therapeutics' web site is provided as a service only and may not always contain the most current information. However, updates will be made frequently. The site includes sections for news, science, about us, contact, and legal notices.
Q8: What is the company's stance on data protection and privacy?
A8: According to the Privacy Policy section of the website, Leucadia Therapeutics is committed to protecting user information and has implemented measures to ensure its security. However, users are advised to review any information with their individual physician or medical practitioner for specific medical advice.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
